» Authors » Yoon Joong Kang

Yoon Joong Kang

Explore the profile of Yoon Joong Kang including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 151
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Wook Lee J, Kang Y, Choi H, Yoon Y
J Microbiol Biotechnol . 2018 Apr; 28(6):839-848. PMID: 29642289
(CC) is widely used in Asian countries to treat inflammatory diseases. We investigated the anti-inflammatory activity of the aqueous fraction separated from CC extract and of berberine, its key bioactive...
2.
Kang Y, Zeng W, Song W, Reinhold B, Choi J, Brusic V, et al.
Br J Haematol . 2013 Sep; 163(3):343-51. PMID: 24032635
Despite the recent development of effective therapeutic agents against multiple myeloma (MM), new therapeutic approaches, including immunotherapies, remain to be developed. Here we identified novel human leucocyte antigen (HLA)-A*0201 (HLA-A2)-restricted...
3.
Kang Y, Chang J, Kim D
J Nanosci Nanotechnol . 2012 Sep; 12(7):5763-8. PMID: 22966650
The effective phase transfer of hydrophobic nanocrystals synthesized in nonpolar solvents into polar solvents remains great challenge for their nanomedicinal applications. To resolve this issue, the exsiting strategies for phase...
4.
Kim D, Chang J, Kang Y
J Nanosci Nanotechnol . 2012 Sep; 12(7):5191-8. PMID: 22966544
Antigen delivery using nanoparticles becomes useful and novel strategy to develop immunotherapeutic approaches against cancer. In the current study, we examined the feasibility of SPIONs-mediated delivery of antigenic peptides to...
5.
Kang J, Chang C, Nam H, Kim S, Ahn K, Seok H, et al.
Cell Oncol (Dordr) . 2011 Mar; 34(1):11-21. PMID: 21360263
Background: Phospholipase C-γl (PLC-γl) is known to play a critical role in cell adhesion and migration and is highly expressed in metastatic tumors. In the current study, we found that...
6.
Zhang Z, Tongchusak S, Mizukami Y, Kang Y, Ioji T, Touma M, et al.
Biomaterials . 2011 Feb; 32(14):3666-78. PMID: 21345488
Nanotechnology-based antigen delivery has been developing as a vaccine strategy due to its dose-sparing and prolonged antigen presentation features. In the current study, we examined the feasibility of nanoparticle (NP)-mediated...
7.
Ho V, Vanneman M, Kim H, Sasada T, Kang Y, Pasek M, et al.
Proc Natl Acad Sci U S A . 2009 Sep; 106(37):15825-30. PMID: 19717467
Through an immune-mediated graft-versus-leukemia effect, allogeneic hematopoietic stem cell transplantation (HSCT) affords durable clinical benefits for many patients with hematologic malignancies. Nonetheless, subjects with high-risk acute myeloid leukemia or advanced...